diosgenin has been researched along with Amyloid Deposits in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Greeson, J; Lecanu, L; McCourty, A; Papadopoulos, V; Rammouz, G; Sidahmed, EK | 1 |
| Kuboyama, T; Nemere, I; Tohda, C; Umezaki, M; Urano, T | 1 |
2 other study(ies) available for diosgenin and Amyloid Deposits
| Article | Year |
|---|---|
Caprospinol reduces amyloid deposits and improves cognitive function in a rat model of Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Astrocytes; Caproates; Cognition Disorders; Diosgenin; Disease Models, Animal; Gliosis; Hippocampus; Male; Maze Learning; Memory Disorders; Nerve Degeneration; Neuroprotective Agents; Phosphorylation; Plaque, Amyloid; Prosencephalon; Rats; Rats, Long-Evans; Spirostans; tau Proteins | 2010 |
Diosgenin is an exogenous activator of 1,25D₃-MARRS/Pdia3/ERp57 and improves Alzheimer's disease pathologies in 5XFAD mice.
Topics: Alzheimer Disease; Animals; Antibodies, Monoclonal; Antibodies, Neutralizing; Axons; Cerebellar Cortex; Diosgenin; Disease Models, Animal; Female; Gene Knockdown Techniques; Male; Memory Disorders; Mice; Molecular Docking Simulation; Neurons; Plaque, Amyloid; Presynaptic Terminals; Protein Conformation; Protein Disulfide-Isomerases; Protein Kinase Inhibitors | 2012 |